 |
Piperazines - Administration & dosage
Research News and Information
Monday, November 23, 2009
13 Dec 2009 
BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) with best available donor for children with Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) has previously been considered standard practice. Since the introduction of ... Read more...
3 Oct 2009 PURPOSE: Imatinib mesylate is a targeted agent that may be used against Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), one of the highest risk pediatric ALL groups. PATIENTS AND METHODS: We evaluated whether imatinib (340 ... Read more...
In vivo interactions between BZP and TFMPP (party pill drugs).
23 Sep 2009 AIM: This study explores potential drug-drug interactions between BZP and TFMPP. This was achieved by comparing the metabolism and pharmacokinetics of BZP and TFMPP when taken together with previously published data on their individual metabolism ... Read more...
Latest indexed articles for 'Piperazines - Administration & dosage'
These are the very latest articles for this heading:
- Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). 13 Dec 2009
- Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. 3 Oct 2009
- In vivo interactions between BZP and TFMPP (party pill drugs). 23 Sep 2009
- Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. 16 Sep 2009
- Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R). 13 Sep 2009
- Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. 9 Sep 2009
- A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists. 8 Sep 2009
- Challenges in oral antiplatelet therapy: ST-segment elevation myocardial infarction. 5 Sep 2009
- Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder. 30 Aug 2009
- Activation induced by high-dose ziprasidone: a case report.
30 Aug 2009 - Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study. 30 Aug 2009
- Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. 30 Aug 2009
- High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses. 29 Aug 2009
- Cardiovascular disease gets personal. 18 Aug 2009
- The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis. 16 Aug 2009
- [Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia] 9 Aug 2009
- Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects. 30 Jul 2009
- Successful weaning of nitric oxide facilitated by a single dose of sildenafil in a baby with persistent pulmonary hypertension of the newborn. 30 Jul 2009
- A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol. 30 Jul 2009
- Ranolazine: new drug. Stable angina: not worth the risk. 30 Jul 2009
See a longer list of these articles.
Technical information about 'Piperazines'
Registry Number: 0
Descriptor UI: D010879
Alternative terms: Piperazines;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D03.383.606;